Beckman Coulter Diagnostics – Global Alzheimer’s Platform Foundation

Beckman Coulter Diagnostics Joins the Transformative Bio-Hermes-002 Study as New Partner

January 23, 2025

Washington D.C., Jan. 23, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Beckman Coulter Diagnostics as a strategic partner in the Bio-Hermes-002 study. This first-time collaboration will enhance this unique, observational platform study that compares blood-based and digital biomarkers across a broad range of clinical cognitive conditions, MRI and PET images […]